http://eyewiretoday.com/ Newest Articles en-us Fri, 3 Sep 2010 20:09:34 GMT Fri, 3 Sep 2010 20:09:34 GMT Eyetube.net http://eyewiretoday.com/view.asp?url=20100903-abbott_abandons_sale_of_vaccine_unit Abbott Laboratories pulled the plug on the sale of its European flu-vaccine business when initial bids came in below the company's expectations. The auction, which Abbott started in June, drew interest from four or five bidders, but the offers, which... Fri, 3 Sep 2010 13:15:00 GMT http://eyewiretoday.com/view.asp?url=20100903-more_americans_taking_rx_drugs Nearly half of all Americans -- 48% -- took at least one prescription drug in a one-month period in 2007-2008, a four percentage point hike over a decade, researchers found. Among those 60 and older, 88.4% took at least one Rx medication, as did near... Fri, 3 Sep 2010 13:13:00 GMT http://eyewiretoday.com/view.asp?url=20100903-growth_of_employer_plans_foreseen_with_health_reform Employer-sponsored insurance will not only remain a cornerstone of the American healthcare system, but it will increase in prevalence in the post-healthcare reform environment, according to several researchers. The Affordable Care Act (ACA) likely wi... Fri, 3 Sep 2010 13:12:00 GMT http://eyewiretoday.com/view.asp?url=20100903-bausch__lomb_names_michael_j_rowe_as_corporate_vice_president_human_resources Bausch + Lomb, the global eye health company, has named Michael J. Rowe as corporate vice president, Human Resources. Mike is an expert in developing and growing high-performance global teams, having counseled multinational organizations across multi... Fri, 3 Sep 2010 13:11:00 GMT http://eyewiretoday.com/view.asp?url=20100902-optimedicas_laser_cataract_surgery_system_to_be_featured_at_escrs Global ophthalmic device company OptiMedica Corp. has announced that clinical results for its laser cataract surgical system will be the subject of three presentations at the European Society of Cataract and Refractive Surgeons annual meeting in Pari... Thu, 2 Sep 2010 13:33:00 GMT http://eyewiretoday.com/view.asp?url=20100902-jama_editor_to_step_down_in_2011 After more than 10 years leading the Journal of the American Medical Association, editor-in-chief Catherine D. DeAngelis, MD, MPH, has announced plans to leave the post next June. A statement issued by the American Medical Association's JAMA and Arch... Thu, 2 Sep 2010 13:27:00 GMT http://eyewiretoday.com/view.asp?url=20100902-allergan_settles_civil_and_criminal_charges Botox manufacturer Allergan will pay $375 million after pleading guilty to a misdemeanor misbranding charge related to off-label use of the cosmetic drug, a statement on the company's website said. In addition to the fine, the company agreed to pay $... Thu, 2 Sep 2010 13:26:00 GMT http://eyewiretoday.com/view.asp?url=20100902-hhs_to_begin_paying_employers_for_early_retirees_health_insurance The federal government will begin paying nearly 2,000 employers from a $5 billion fund to provide health insurance for employees who have retired early, Health and Human Services Secretary Kathleen Sebelius announced Tuesday. The healthcare reform la... Thu, 2 Sep 2010 13:23:00 GMT http://eyewiretoday.com/view.asp?url=20100902-bausch__lomb_releases_single-use_vitreoretinal_asymmetric_peeling_forceps Bausch + Lomb Storz Ophthalmic Instruments announces the U.S. release of a new, single-use, asymmetric peeling forceps for vitreoretinal surgery. The forceps are available in 23- and 25-gauge options for facilities seeking the safety, consistency and... Thu, 2 Sep 2010 13:21:00 GMT http://eyewiretoday.com/view.asp?url=20100902-school_childrens_eyesight_getting_worse_after_summer_vacation Nearly 90 percent of the school children visiting ophthalmology clinics recently have been diagnosed with worsening myopia due to excessive eye strain suffered during the summer break, according to an eye doctor who said Wednesday that television and... Thu, 2 Sep 2010 13:19:00 GMT http://eyewiretoday.com/view.asp?url=20100901-study_examines_visual_outcomes_of_lasik-induced_monovision LASIK-induced monovision increases spectacle independence and is a valid option for myopic patients with presbyopia, according to a study in the American Journal of Ophthalmology.1 The prospective, observational study examined 37 consecutive patients... Wed, 1 Sep 2010 12:58:00 GMT http://eyewiretoday.com/view.asp?url=20100901-eyegenix_artificial_cornea_achieves_major_advancement_towards_curing_corneal_blindness Eyegenix, the ophthalmic division of Cellular Bioengineering, Inc. (CBI), announced that the results of a pilot clinical trial using a synthetic cornea for which Eyegenix holds the exclusive global license for transplantation were published in the pe... Wed, 1 Sep 2010 12:55:00 GMT http://eyewiretoday.com/view.asp?url=20100901-improving_ocular_disease_screening_by_led_illumination_of_the_eye A new imaging system using six different wavelengths to illuminate theinterior of the eyeball (ocular fundus) may pave the way for doctors toeasily screen patients for common diseases of the eye, such asage-related macular degeneration and diabetic r... Wed, 1 Sep 2010 12:54:00 GMT http://eyewiretoday.com/view.asp?url=20100901-hawthorn_may_fight_cataract_development In tests on rat pups, scientists discovered that eye drops containing hawthorn extract helped fight cataracts by revving up antioxidant activity. The world's leading cause of blindness, cataracts develop when fibers in the lens of the eye clump toget... Wed, 1 Sep 2010 12:52:00 GMT http://eyewiretoday.com/view.asp?url=20100901-allergan_inc_receives_fda_approval_for_lumigan_for_the_reduction_of_elevated_intraocular_pressure_in_glaucoma_patients Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved LUMIGAN (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients wi... Wed, 1 Sep 2010 12:45:00 GMT http://eyewiretoday.com/view.asp?url=20100831-tearlab_enters_into_cooperative_marketing_agreement_with_amos_canadian_subsidiary TearLab Corporation and Abbott Medical Optics Inc.s Canadian subsidiary, AMO Canada, today announced that they have entered into a cooperative marketing agreement. Under the agreement, AMO Canadas sales force will directly sell the TearLab Osmolarity... Tue, 31 Aug 2010 12:28:00 GMT http://eyewiretoday.com/view.asp?url=20100831-inspire_stops_clinical_development_of_prolacria_and_amends_agreement_with_allergan Inspire Pharmaceuticals, Inc. has entered into an amended licensing, development and marketing agreement with Allergan, Inc., which revises terms related to the Prolacria (diquafosol tetrasodium ophthalmic solution) 2% development program and Inspire... Tue, 31 Aug 2010 12:19:00 GMT http://eyewiretoday.com/view.asp?url=20100831-toolbox_of_minipromoters_for_gene_research_and_therapy_unvelied_by_ubc_researchers University of British Columbia researchers have led the development of a new "toolbox of MiniPromoters" for research and future therapies on brain, spinal cord and eye function. MiniPromoters are small segments of human DNA with the ability to turn g... Tue, 31 Aug 2010 12:16:00 GMT http://eyewiretoday.com/view.asp?url=20100831-optometrists_encourage_eye_test_for_children_ireland Optometrists are encouraging parents and teachers across the country to take their children for a special eye test as part of its Bright Eyes For Back to School campaign which runs next week (from September 6th to 11th). The campaign by the Associati... Tue, 31 Aug 2010 12:14:00 GMT http://eyewiretoday.com/view.asp?url=20100831-researcher_finds_revolutionary_way_to_treat_eye_cancer A scientist has discoverd a method to prevent damage caused while treating a rare but devastating, eye cancer whose treatment often requires radiation that leaves half of all patients partially blind. The technique developed by Scott Oliver of the Un... Tue, 31 Aug 2010 12:10:00 GMT http://eyewiretoday.com/view.asp?url=20100830-alimera_sciences_iluvien_receives_fda_priority_review_for_the_treatment_of_diabetic_macular_edema Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that the companys New Drug Application (NDA) for Iluvien (fluocinolone... Tue, 31 Aug 2010 00:41:00 GMT http://eyewiretoday.com/view.asp?url=20100830-seeking_quality_education_for_deaf_blind_children_in_todays_environment AER Journal: Research and Practice in Visual Impairment and Blindness presents a special issue, Current Practices with Children Who Are Deaf-Blind, examining education practices and priorities for children who are deaf blind. Articles in the issue ad... Mon, 30 Aug 2010 13:09:00 GMT http://eyewiretoday.com/view.asp?url=20100830-lab_corneas_gives_hope_for_improved_sight Surgical implantation ofbiosynthetic corneas may restore vision and promote nerve regeneration inpatients with corneal damage and significant vision loss, according to resultsof a 2-year clinical study.1 In the phase 1,investigator-sponsored study, p... Mon, 30 Aug 2010 13:08:00 GMT http://eyewiretoday.com/view.asp?url=20100830-iphone_enables_online_buyers_to_measure_pd A new application for Apple's iPhone enables users to measure both their near and far pupillary distances (PD) in order to make online purchases of spectacles. The program's manufacturer, Sunmore Systems, tells customers that the 'easy to use' applic... Mon, 30 Aug 2010 13:06:00 GMT http://eyewiretoday.com/view.asp?url=20100830-genzyme_ceo_rejects_sanofi_bid_as_too_low_to_discuss Genzyme Corp. rejected Sanofi- Aventis SAs $18.5 billion cash acquisition bid, saying it undervalued the U.S. biotechnology companys pipeline and efforts to fix manufacturing concerns. The response may spark a hostile bid by Sanofi after the Paris-ba... Mon, 30 Aug 2010 13:01:00 GMT